2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB)

BACKGROUND: Ceftobiprole medocaril is an intravenously (IV) administered cephalosporin that is rapidly converted to the active moiety ceftobiprole in vivo. Ceftobiprole medocaril is currently being developed for the treatment of patients with SAB, including infective endocarditis. PK-PD target attai...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhavnani, Sujata M, Hammel, Jeffrey P, Rinaldo, Anthony J, Smart, Jennifer, Litherland, Karine, Duncan, Leonard R, Jones, Mark E, Engelhardt, Marc, Ambrose, Paul G, Rubino, Christopher M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678603/
http://dx.doi.org/10.1093/ofid/ofad500.2149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678603/
http://dx.doi.org/10.1093/ofid/ofad500.2149

Ejemplares similares